tizanidine
- Product NDC
- 71335-0003
- 11-digit product format
- 713350003
- Labeler code
- 71335
- Product ID
- 71335-0003_164e64c4-059a-4d5c-a948-2481ea6a4252
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- tizanidine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA076533
- Marketing category
- ANDA
- Marketing start
- 2004-01-16
- Marketing end
- 0000-00-00
- Substance
- TIZANIDINE HYDROCHLORIDE
- Active strength
- 2 mg/1
- Pharmacologic classes
- Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71335-0003-1 | 71335000301 | 30 TABLET in 1 BOTTLE (71335-0003-1) | 30 tablet | 2009-07-06 | 0000-00-00 | No | No | Current |
| 71335-0003-2 | 71335000302 | 60 TABLET in 1 BOTTLE (71335-0003-2) | 60 tablet | 2009-07-06 | 0000-00-00 | No | No | Current |
| 71335-0003-3 | 71335000303 | 90 TABLET in 1 BOTTLE (71335-0003-3) | 90 tablet | 2009-07-06 | 0000-00-00 | No | No | Current |
| 71335-0003-4 | 71335000304 | 120 TABLET in 1 BOTTLE (71335-0003-4) | 120 tablet | 2009-07-06 | 0000-00-00 | No | No | Current |
| 71335-0003-5 | 71335000305 | 100 TABLET in 1 BOTTLE (71335-0003-5) | 100 tablet | 2009-07-06 | 0000-00-00 | No | No | Current |
| 71335-0003-6 | 71335000306 | 84 TABLET in 1 BOTTLE (71335-0003-6) | 84 tablet | 2009-07-06 | 0000-00-00 | No | No | Current |
| 71335-0003-7 | 71335000307 | 28 TABLET in 1 BOTTLE (71335-0003-7) | 28 tablet | 2009-07-06 | 0000-00-00 | No | No | Current |
| 71335-0003-8 | 71335000308 | 21 TABLET in 1 BOTTLE (71335-0003-8) | 21 tablet | 2009-07-06 | 0000-00-00 | No | No | Current |
| 71335-0003-9 | 71335000309 | 160 TABLET in 1 BOTTLE (71335-0003-9) | 160 tablet | 2009-07-06 | 0000-00-00 | No | No | Current |